Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: A phase II study

By Kümmel Sherko   Thomas Anke   Paepke Stefan   Schwarz Marion   Heinrich Georg   Wetzel Andrea   Elling Dirk   Kohls Andreas   Lichtenegger Werner   Blohmer Jens-Uwe  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 248-254

Informa Healthcare

Access to resources Recommend Favorite

The Effectiveness of S-1 Based Sequential Chemotherapy as Second-Line Treatment for Advanced/Recurrent Gastric Cancer

By Sugimoto Naotoshi   Narahara Hiroyuki   Sakai Daisuke   Yamamoto Sachiko   Fumoto Shoichi   Yagi Toshinari   Imamura Fumio   Iishi Hiroyasu   Tatsuta Masaharu  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 417-424

Sunmedia

Access to resources Recommend Favorite

New Predictors of Response to Neoadjuvant Chemotherapy and Survival for Invasive Thymoma: a Retrospective Analysis

By Mineo Tommaso  

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 3022-3029

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer

By Cooper Brenda   Radivoyevitch Tomas   Overmoyer Beth   Shenk Robert   Pham Huong   Samuels Judith   Parry Margaret   Silverman Paula  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 311-318

Springer Publishing Company

Access to resources Recommend Favorite

Advanced squamous lung carcinoma in a patient experiencing long-term survival following repeated responses to gemcitabine and cisplatin chemotherapy: A case report

By Yu Min   Zhang Shuang   Li Yanying   Ding Zhenyu   Peng Feng  

Oncology Letters, Vol. 9, Iss. 6, 2015-06 ,pp. : 2874-2878

Spandidos Publications

Access to resources Recommend Favorite